Approval · Notice of Compliance 2008 · 1999
VECURONIUM: Notice of Compliance 2008
Issued September 1, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2008
- Date
- September 1, 1999
- Company
- Schein Pharmaceutical Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Non-depolarizing skeletal neuromuscular blocking agent
- Canadian reference product
- NORCURON
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VECURONIUM | 02230705 | Cancelled Post Market |
| VECURONIUM | 02230706 | — |
Medicinal ingredients
- VECURONIUM BROMIDE 10 MG per VIAL
- VECURONIUM BROMIDE 20 MG per VIAL